Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.96 |
| ▸ | PPARG | P37231 | 5/20 | 0.81 |
| ▸ | PPARD | Q03181 | 5/20 | 0.81 |
| ▸ | PPARA | Q07869 | 5/20 | 0.81 |
| ▸ | F7 | P08709 | 5/20 | 0.81 |
| ▸ | F3 | P13726 | 5/20 | 0.81 |
| ▸ | TERT | O14746 | 3/20 | 0.81 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.81 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.81 |
| ▸ | FABP4 | P15090 | 3/20 | 0.81 |
| ▸ | MAPT | P10636 | 2/20 | 0.81 |
| ▸ | BLM | P54132 | 2/20 | 0.81 |
| ▸ | LMNA | P02545 | 2/20 | 0.81 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.81 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.81 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.81 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.81 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.81 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.81 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1647674 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL2230814 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL1271128 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL1017653 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL23698235 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL23698236 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL16994321 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL1647672 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL3399216 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL1017655 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1921 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746844-A1 | PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2026-05-27 | — | — | EP | claimed |
| EP-3956283-B1 | PROCESS OF PREPARING POLYOL-BASED ESTERS OF ACYL-CAPPED HYDROXY CARBOXYLIC ACIDS | KETOLIPIX THERAPEUTICS GMBH (DE) | 2026-05-20 | — | — | EP | claimed |
| US-12577688-B2 | Electrochemical oxidation of fatty acids and fatty acid esters to form monocarboxylic acids and alpha-omega-dicarboxylic acids | EVONIK OPERATIONS GMBH (DE) | 2026-03-17 | — | — | US | claimed |
| US-20260071021-A1 | PRODUCTION OF POLYURETHANE FOAM | EVONIK OPERATIONS GMBH (DE) | 2026-03-12 | — | — | US | claimed |
| WO-2026041693-A1 | HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS | SPSV B.V. (NL) | 2026-02-26 | — | — | WO | claimed |
| EP-4700098-A1 | HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS | SPSV B.V. (NL) | 2026-02-25 | — | — | EP | claimed |
| EP-4694699-A2 | COMPOSITIONS AND METHODS OF CONTROLLING MAMMALIAN SATIETY | VitaKey Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| US-20250223709-A1 | ELECTROCHEMICAL OXIDATION OF FATTY ACIDS AND FATTY ACID ESTERS TO FORM MONOCARBOXYLIC ACIDS AND ALPHA-OMEGA-DICARBOXYLIC ACIDS | EVONIK OPERATIONS GMBH (DE) | 2025-07-10 | — | — | US | claimed |
| EP-4581072-A1 | PRODUCTION OF POLYURETHANE FOAM | Evonik Operations GmbH (DE) | 2025-07-09 | — | — | EP | claimed |
| WO-2025125085-A1 | ORAL PRODUCT FOR DELIVERY OF NICOTINE COMPRISING A NICOTINE SALT OF A FATTY ACID | CONTRAF-NICOTEX-TOBACCO GMBH (DE) | 2025-06-19 | — | — | WO | claimed |
| US-20030204871-A1 | Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position | CAHOON EDGAR BENJAMIN (US) | 2003-10-30 | — | — | US | claimed |
| US-6593514-B1 | Chimeric gene comprising an isolated nucleic acid fragment encoding a plant fatty acid modifying enzyme; can be used to create transgenic plants having altered lipid profiles; use in drying oils, lubricants, detergents, animal feed additives | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-07-15 | — | — | US | claimed |
| CN-1384882-A | Fatty acid desaturase gene from plants | BASF AG (DE) | 2002-12-11 | — | — | CN | claimed |
| WO-2002088159-A1 | PHARMACEUTICALLY ACTIVE URIDINE ESTERS | TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2002-11-07 | — | — | WO | claimed |
| WO-2001085968-A9 | PRODUCTION OF CONJUGATED LINOLEIC AND LINOLENIC ACIDS IN PLANTS | BIORIGINAL FOOD & SCIENCE CORP (CA) | 2002-08-15 | — | — | WO | claimed |
| EP-1208203-A2 | METHOD FOR THE PRODUCTION OF CALENDIC ACID, A FATTY ACID CONTAINING DELTA-8,10,12 CONJUGATED DOUBLE BONDS AND DIMORPHECOLIC ACID, A FATTY ACID CONTAINING A 9-HYDROXY GROUP AND DELTA-10,12 CONJUGATED DOUBLE BONDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-05-29 | — | — | EP | claimed |
| US-20020045232-A1 | Production of conjugated linoleic and linolenic acids in plants | BIORIGINAL FOOD & SCIENCE CORP. (CA) | 2002-04-18 | — | — | US | claimed |
| EP-1175901-A1 | PEROXISOME ACTIVATOR-RESPONSIVE RECEPTOR AGONISTS | Kaneka Corporation (JP) | 2002-01-30 | — | — | EP | claimed |
| WO-2001085968-A2 | PRODUCTION OF CONJUGATED LINOLEIC AND LINOLENIC ACIDS IN PLANTS | BIORIGINAL FOOD & SCIENCE CORP. (CA) | 2001-11-15 | — | — | WO | claimed |
| WO-2001012800-A2 | METHOD FOR THE PRODUCTION OF CALENDIC ACID, A FATTY ACID CONTAINING DELTA-8,10,12 CONJUGATED DOUBLE BONDS AND DIMORPHECOLIC ACID, A FATTY ACID CONTAINING A 9-HYDROXY GROUP AND DELTA-10,12 CONJUGATED DOUBLE BONDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-02-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071021-A1 | PRODUCTION OF POLYURETHANE FOAM | PUF60, QPCTL, ABAT | FASN 1446/4885PPARG 2666/4885PPARD 2372/4885 |
| US-12577688-B2 | Electrochemical oxidation of fatty acids and fatty acid esters to form monocarboxylic acids and alpha-omega-dicarboxylic acids | ELOVL1, ELOVL3, FFAR1 | FASN 6/4885PPARG 318/4885PPARD 564/4885 |
| US-20030204871-A1 | Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position | FADS2, FASN, FADS1 | FASN 2/4885PPARG 90/4885PPARD 111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.